Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Differences in clinical valve size selection and valve size selection for patient-specific computer simulation in transcatheter aortic valve replacement (TAVR): a retrospective multicenter analysis.

El Faquir N, Rocatello G, Rahhab Z, Bosmans J, De Backer O, Van Mieghem NM, Mortier P, de Jaegere PPT.

Int J Cardiovasc Imaging. 2019 Sep 12. doi: 10.1007/s10554-019-01688-5. [Epub ahead of print]

PMID:
31515695
2.

Short-term changes of blood pressure and aortic stiffness in older patients after transcatheter aortic valve implantation.

Goudzwaard JA, Disegna E, de Ronde-Tillmans MJ, Lenzen MJ, de Jaegere PP, Mattace-Raso FU.

Clin Interv Aging. 2019 Aug 2;14:1379-1386. doi: 10.2147/CIA.S211328. eCollection 2019.

3.

Long-term outcome in patients treated with first- versus second-generation drug-eluting stents for the treatment of unprotected left main coronary artery stenosis.

van Zandvoort LJC, van Bommel RJ, Masdjedi K, Tovar Forero MN, Lemmert MM, Wilschut J, Diletti R, de Jaegere PPT, Zijlstra F, van Mieghem NM, Daemen J.

Catheter Cardiovasc Interv. 2019 Jul 13. doi: 10.1002/ccd.28387. [Epub ahead of print]

PMID:
31301161
4.

Fractional flow reserve guided percutaneous coronary intervention optimization directed by high-definition intravascular ultrasound versus standard of care: Rationale and study design of the prospective randomized FFR-REACT trial.

van Zandvoort LJC, Masdjedi K, Tovar Forero MN, Lenzen MJ, Ligthart J, Diletti R, Lemmert ME, Wilschut J, de Jaegere PPT, Zijlstra F, van Mieghem NM, Daemen J.

Am Heart J. 2019 Jul;213:66-72. doi: 10.1016/j.ahj.2019.03.017. Epub 2019 Apr 10.

PMID:
31128504
5.

Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.

Tovar Forero MN, van Zandvoort L, Masdjedi K, Diletti R, Wilschut J, de Jaegere PP, Zijlstra F, Van Mieghem NM, Daemen J.

Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28304. [Epub ahead of print]

PMID:
31033171
6.

Impact of baseline cigarette smoking status on clinical outcome after transcatheter aortic valve replacement.

Abawi M, van Gils L, Agostoni P, van Mieghem NM, Kooistra NHM, van Dongen CS, van Jaarsveld RC, de Jaegere PPT, Doevendans PAFM, Stella PR.

Catheter Cardiovasc Interv. 2019 Mar 22. doi: 10.1002/ccd.28175. [Epub ahead of print]

PMID:
30901147
7.

Life-long clinical outcome after the first myocardial revascularization procedures: 40-year follow-up after coronary artery bypass grafting and percutaneous coronary intervention in Rotterdam.

Milojevic M, Thuijs DJFM, Head SJ, Domingues CT, Bekker MWA, Zijlstra F, Daemen J, de Jaegere PPT, Kappetein AP, van Domburg RT, Bogers AJJC.

Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):852-859. doi: 10.1093/icvts/ivz006.

PMID:
30753554
8.

Explanation of Postprocedural Fractional Flow Reserve Below 0.85.

van Zandvoort LJC, Masdjedi K, Witberg K, Ligthart J, Tovar Forero MN, Diletti R, Lemmert ME, Wilschut J, de Jaegere PPT, Boersma E, Zijlstra F, Van Mieghem NM, Daemen J.

Circ Cardiovasc Interv. 2019 Feb;12(2):e007030. doi: 10.1161/CIRCINTERVENTIONS.118.007030.

PMID:
30732469
9.

New Conduction Abnormalities After Transcatheter Aortic Valve Replacement: An Innocent Bystander or a Serious Adverse Event Indeed?

de Jaegere PPT, Houthuizen P, Prinzen FW.

JACC Cardiovasc Interv. 2019 Jan 14;12(1):62-64. doi: 10.1016/j.jcin.2018.11.038. No abstract available.

PMID:
30621979
10.

The Erasmus Frailty Score is associated with delirium and 1-year mortality after Transcatheter Aortic Valve Implantation in older patients. The TAVI Care & Cure program.

Goudzwaard JA, de Ronde-Tillmans MJAG, El Faquir N, Acar F, Van Mieghem NM, Lenzen MJ, de Jaegere PPT, Mattace-Raso FUS.

Int J Cardiol. 2019 Feb 1;276:48-52. doi: 10.1016/j.ijcard.2018.10.093. Epub 2018 Oct 28.

PMID:
30409734
11.

An update on the use of anticoagulant therapy in ST-segment elevation myocardial infarction.

van Gameren M, Lemmert ME, Wilschut JM, Daemen J, De Jaegere PPT, Zijlstra F, Van Mieghem NMDA, Diletti R.

Expert Opin Pharmacother. 2018 Sep;19(13):1441-1450. doi: 10.1080/14656566.2018.1512583. Epub 2018 Sep 5. Review.

PMID:
30185087
12.

Moderate Aortic Stenosis and Reduced Left Ventricular Ejection Fraction: Current Evidence and Challenges Ahead.

Spitzer E, Ren B, Kroon H, van Gils L, Manintveld O, Daemen J, Zijlstra F, de Jaegere PP, Geleijnse ML, Van Mieghem NM.

Front Cardiovasc Med. 2018 Aug 17;5:111. doi: 10.3389/fcvm.2018.00111. eCollection 2018. Review.

13.

Long-term follow-up of quality of life in high-risk patients undergoing transcatheter aortic valve implantation for symptomatic aortic valve stenosis.

De Ronde-Tillmans MJ, de Jager TA, Goudzwaard JA, El Faquir N, van Mieghem NM, Zijlstra F, Utens EM, Mattace-Raso FU, Lenzen MJ, de Jaegere PP.

J Geriatr Cardiol. 2018 Apr;15(4):261-267. doi: 10.11909/j.issn.1671-5411.2018.04.003.

14.

Impact of device-host interaction on paravalvular aortic regurgitation with different transcatheter heart valves.

Rodríguez-Olivares R, El Faquir N, Rahhab Z, van Gils L, Ren B, Sakhi R, Geleijnse ML, van Domburg R, de Jaegere PPT, Zamorano Gómez JL, Van Mieghem NM.

Cardiovasc Revasc Med. 2019 Feb;20(2):126-132. doi: 10.1016/j.carrev.2018.05.004. Epub 2018 May 6.

PMID:
29779973
15.

Conduction dynamics after transcatheter aortic valve implantation and implications for permanent pacemaker implantation and early discharge: the CONDUCT-study.

van Gils L, Baart S, Kroon H, Rahhab Z, El Faquir N, Rodriguez Olivares R, Aga Y, Maugenest AM, Theuns DA, Boersma E, Szili Torok T, De Jaegere PP, Van Mieghem NM.

Europace. 2018 Dec 1;20(12):1981-1988. doi: 10.1093/europace/euy074.

PMID:
29688322
16.

Kissing balloon technique to secure the neo-left ventricular outflow tract in transcatheter mitral valve implantation.

Rahhab Z, Ren B, de Jaegere PPT, Van Mieghem NMDA.

Eur Heart J. 2018 Jun 14;39(23):2220. doi: 10.1093/eurheartj/ehy112. No abstract available.

PMID:
29518218
17.

A case-vignette based assessment of patient's perspective on coronary revascularization strategies, the OPINION study.

Masdjedi K, Daemen J, Diletti R, Wilschut J, Utens E, de Jaegere PP, Lemmert ME, Kappetein AP, Zijlstra F, van Domburg R, Van Mieghem NM.

J Cardiol. 2018 Aug;72(2):149-154. doi: 10.1016/j.jjcc.2018.01.009. Epub 2018 Mar 1.

18.

Right ventricular systolic function in patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis.

Ren B, Spitzer E, Geleijnse ML, Zijlstra F, de Jaegere PPT, Van Mieghem NM, Tijssen JG.

Int J Cardiol. 2018 Apr 15;257:40-45. doi: 10.1016/j.ijcard.2018.01.117. Epub 2018 Jan 31. Review.

PMID:
29422266
19.

Long-Term Structural Integrity and Durability of the Medtronic CoreValve System After Transcatheter Aortic Valve Replacement.

El Faquir N, Ren B, Faure M, de Ronde M, Geeve P, Maugenest AM, Kardys I, Geleijnse ML, de Jaegere PP, Budde RPJ, Van Mieghem NM.

JACC Cardiovasc Imaging. 2018 May;11(5):781-783. doi: 10.1016/j.jcmg.2017.08.019. Epub 2017 Nov 15. No abstract available.

20.

Clinical Characteristics and Management of Coronary Artery Perforations: A Single-Center 11-Year Experience and Practical Overview.

Lemmert ME, van Bommel RJ, Diletti R, Wilschut JM, de Jaegere PP, Zijlstra F, Daemen J, Van Mieghem NM.

J Am Heart Assoc. 2017 Sep 22;6(9). pii: e007049. doi: 10.1161/JAHA.117.007049.

21.

Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.

Van Gils L, Kroon H, Daemen J, Ren C, Maugenest AM, Schipper M, De Jaegere PP, Van Mieghem NM.

Catheter Cardiovasc Interv. 2018 Mar 1;91(4):790-797. doi: 10.1002/ccd.27323. Epub 2017 Sep 12.

PMID:
28895285
22.

How should I treat a patient with a symptomatic and severe low-flow low-gradient aortic stenosis and an incidental abdominal aortic aneurysm?

Rahhab Z, Ten Raa S, van der Ploeg N, Van Mieghem NM, Verhagen H, de Jaegere PPT, Arsalan M, Kim W, Walther T, Tchétché D.

EuroIntervention. 2017 Jul 20;13(4):491-494. doi: 10.4244/EIJ-D-16-00461. No abstract available.

23.

Prognostic Implications of Moderate Aortic Stenosis in Patients With Left Ventricular Systolic Dysfunction.

van Gils L, Clavel MA, Vollema EM, Hahn RT, Spitzer E, Delgado V, Nazif T, De Jaegere PP, Geleijnse ML, Ben-Yehuda O, Bax JJ, Leon MB, Pibarot P, Van Mieghem NM.

J Am Coll Cardiol. 2017 May 16;69(19):2383-2392. doi: 10.1016/j.jacc.2017.03.023.

24.

The Promus Premier everolimus-eluting platinum chromium stent with durable polymer evaluated in a real world all-comer population in Rotterdam cardiology hospital (the P-SEARCH registry).

Lemmert ME, van Mieghem NM, van Geuns RJ, Diletti R, van Bommel RJ, van Domburg RT, de Jaegere PP, Regar E, Zijlstra F, Boersma E, Daemen J.

Int J Cardiol. 2017 Aug 1;240:103-107. doi: 10.1016/j.ijcard.2017.03.054. Epub 2017 Mar 20.

PMID:
28385356
25.

Relation between calcium burden, echocardiographic stent frame eccentricity and paravalvular leakage after corevalve transcatheter aortic valve implantation.

Di Martino LFM, Soliman OII, van Gils L, Vletter WB, Van Mieghem NM, Ren B, Galema TW, Schultz C, de Jaegere PPT, Di Biase M, Geleijnse ML.

Eur Heart J Cardiovasc Imaging. 2017 Jun 1;18(6):648-653. doi: 10.1093/ehjci/jex009.

PMID:
28369281
26.

Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study.

Van Mieghem NM, Latib A, van der Heyden J, van Gils L, Daemen J, Sorzano T, Ligthart J, Witberg K, de Kroon T, Maor N, Mangieri A, Montorfano M, de Jaegere PP, Colombo A, Roubin G.

JACC Cardiovasc Interv. 2017 Mar 27;10(6):613-619. doi: 10.1016/j.jcin.2016.12.277.

27.

Transcatheter Heart Valve Selection and Permanent Pacemaker Implantation in Patients With Pre-Existent Right Bundle Branch Block.

van Gils L, Tchetche D, Lhermusier T, Abawi M, Dumonteil N, Rodriguez Olivares R, Molina-Martin de Nicolas J, Stella PR, Carrié D, De Jaegere PP, Van Mieghem NM.

J Am Heart Assoc. 2017 Mar 3;6(3). pii: e005028. doi: 10.1161/JAHA.116.005028.

28.

Postoperative analysis of the mechanical interaction between stent and host tissue in patients after transcatheter aortic valve implantation.

Hopf R, Sündermann SH, Born S, Ruiz CE, Van Mieghem NM, de Jaegere PP, Maisano F, Falk V, Mazza E.

J Biomech. 2017 Feb 28;53:15-21. doi: 10.1016/j.jbiomech.2016.12.038. Epub 2016 Dec 30.

PMID:
28139202
29.

Determinants of aortic regurgitation after transcatheter aortic valve implantation. An observational study using multi-slice computed tomography-guided sizing.

Rahhab Z, El Faquir N, Rodríguez-Olivares R, Ren C, van Mieghem N, Geleijnse ML, Schultz C, van Domburg R, de Jaegere PP.

J Cardiovasc Surg (Torino). 2017 Aug;58(4):598-605. doi: 10.23736/S0021-9509.17.09391-0. Epub 2017 Jan 27.

PMID:
28128540
30.

Comparison of valve performance of the mechanically expanding Lotus and the balloon-expanded SAPIEN3 transcatheter heart valves: an observational study with independent core laboratory analysis.

Soliman OII, El Faquir N, Ren B, Spitzer E, van Gils L, Jonker H, Geleijnse ML, van Es GA, Tijssen JG, van Mieghem NM, de Jaegere PPT.

Eur Heart J Cardiovasc Imaging. 2018 Feb 1;19(2):157-167. doi: 10.1093/ehjci/jew280.

PMID:
28064153
31.

Electrical remodelling in patients with iatrogenic left bundle branch block.

Engels EB, Poels TT, Houthuizen P, de Jaegere PP, Maessen JG, Vernooy K, Prinzen FW.

Europace. 2016 Dec;18(suppl 4):iv44-iv52. doi: 10.1093/europace/euw350.

PMID:
28011830
32.

Quantitative Doppler for Estimation of Paravalvular Leakage after Transcatheter Aortic Valve Implantation.

M Di Martino LF, I Soliman OI, Vletter WB, Ren B, de Vries T, Galema TW, Van Mieghem NM, de Jaegere PP, Geleijnse ML.

J Heart Valve Dis. 2016 May;25(3):289-295.

PMID:
27989038
33.

Early stentframe thrombosis complicating transcatheter valve in transcatheter valve implantation.

van Gils L, Budde RPJ, De Jaegere PP, Van Mieghem NM.

Eur Heart J. 2017 Jul 21;38(28):2231. doi: 10.1093/eurheartj/ehw538. No abstract available.

PMID:
27941017
34.

Expanded clinical use of everolimus eluting bioresorbable vascular scaffolds for treatment of coronary artery disease.

Diletti R, Ishibashi Y, Felix C, Onuma Y, Nakatani S, van Mieghem NM, Regar E, Valgimigli M, de Jaegere PP, van Ditzhuijzen N, Fam JM, Ligthart JMR, Lenzen MJ, Serruys PW, Zijlstra F, Jan van Geuns R.

Catheter Cardiovasc Interv. 2017 Jul;90(1):58-69. doi: 10.1002/ccd.26832. Epub 2016 Nov 29.

PMID:
27896897
35.

Patient-specific computer modelling - its role in the planning of transcatheter aortic valve implantation.

El Faquir N, Ren B, Van Mieghem NM, Bosmans J, de Jaegere PP.

Neth Heart J. 2017 Feb;25(2):100-105. doi: 10.1007/s12471-016-0923-6. Review.

36.

Conceptual model for early health technology assessment of current and novel heart valve interventions.

Huygens SA, Rutten-van Mölken MP, Bekkers JA, Bogers AJ, Bouten CV, Chamuleau SA, de Jaegere PP, Kappetein AP, Kluin J, van Mieghem NM, Versteegh MI, Witsenburg M, Takkenberg JJ.

Open Heart. 2016 Oct 14;3(2):e000500. eCollection 2016.

37.

Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy.

Giustino G, Van der Boon RM, Molina-Martin de Nicolas J, Dumonteil N, Chieffo A, de Jaegere PP, Tchetche D, Marcheix B, Millischer D, Cassagneau R, Carrié D, Van Mieghem NM, Colombo A.

EuroIntervention. 2016 Oct 20;12(9):1185-1193. doi: 10.4244/EIJV12I9A192.

38.

Transcatheter Lotus Valve Implantation in a Stenotic Mitral Valve.

Ren B, Rahhab Z, von der Thüsen J, Daemen J, Geleijnse ML, de Jaegere PP, Kappetein AP, Van Mieghem NM.

JACC Cardiovasc Interv. 2016 Nov 14;9(21):e215-e217. doi: 10.1016/j.jcin.2016.08.026. Epub 2016 Oct 12. No abstract available.

39.

MANTA, a novel plug-based vascular closure device for large bore arteriotomies: technical report.

van Gils L, Daemen J, Walters G, Sorzano T, Grintz T, Nardone S, Lenzen M, De Jaegere PP, Roubin G, Van Mieghem NM.

EuroIntervention. 2016 Sep 18;12(7):896-900. doi: 10.4244/EIJV12I7A147.

40.

Limitations and difficulties of echocardiographic short-axis assessment of paravalvular leakage after corevalve transcatheter aortic valve implantation.

Geleijnse ML, Di Martino LF, Vletter WB, Ren B, Galema TW, Van Mieghem NM, de Jaegere PP, Soliman OI.

Cardiovasc Ultrasound. 2016 Sep 6;14(1):37. doi: 10.1186/s12947-016-0080-5. Review.

41.

Mitral Valve Injury After MitraClip Implantation.

Rahhab Z, Ren B, Oei F, de Jaegere PP, Van Mieghem NM.

JACC Cardiovasc Interv. 2016 Sep 26;9(18):e185-6. doi: 10.1016/j.jcin.2016.07.007. Epub 2016 Aug 31. No abstract available.

42.

Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.

Barbanti M, Webb JG, Tamburino C, Van Mieghem NM, Makkar RR, Piazza N, Latib A, Sinning JM, Won-Keun K, Bleiziffer S, Bedogni F, Kapadia S, Tchetche D, Rodés-Cabau J, Fiorina C, Nombela-Franco L, De Marco F, de Jaegere PP, Chakravarty T, Vaquerizo B, Colombo A, Svensson L, Lange R, Nickenig G, Möllmann H, Walther T, Della Rosa F, Elhmidi Y, Dvir D, Brambilla N, Immè S, Sgroi C, Gulino S, Todaro D, Pilato G, Petronio AS, Tamburino C.

Circ Cardiovasc Interv. 2016 Sep;9(9). pii: e003930. doi: 10.1161/CIRCINTERVENTIONS.116.003930.

PMID:
27578840
43.

Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries.

Oemrawsingh RM, Garcia-Garcia HM, van Geuns RJ, Lenzen MJ, Simsek C, de Boer SP, Van Mieghem NM, Regar E, de Jaegere PP, Akkerhuis KM, Ligthart JM, Zijlstra F, Serruys PW, Boersma E.

EuroIntervention. 2016 Aug 20;12(6):734-9. doi: 10.4244/EIJV12I6A118.

44.

Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry.

Felix CM, Fam JM, Diletti R, Ishibashi Y, Karanasos A, Everaert BR, van Mieghem NM, Daemen J, de Jaegere PP, Zijlstra F, Regar ES, Onuma Y, van Geuns RJ.

JACC Cardiovasc Interv. 2016 Aug 22;9(16):1652-63. doi: 10.1016/j.jcin.2016.04.035. Epub 2016 Jul 27.

45.

Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial.

Van Mieghem NM, van Gils L, Ahmad H, van Kesteren F, van der Werf HW, Brueren G, Storm M, Lenzen M, Daemen J, van den Heuvel AF, Tonino P, Baan J, Koudstaal PJ, Schipper ME, van der Lugt A, de Jaegere PP.

EuroIntervention. 2016 Jul 20;12(4):499-507. doi: 10.4244/EIJV12I4A84.

46.

Everolimus-eluting bioresorbable vascular scaffolds implanted in coronary bifurcation lesions: Impact of polymeric wide struts on side-branch impairment.

De Paolis M, Felix C, van Ditzhuijzen N, Fam JM, Karanasos A, de Boer S, van Mieghem NM, Daemen J, Costa F, Bergoli LC, Ligthart JM, Regar E, de Jaegere PP, Zijlstra F, van Geuns RJ, Diletti R.

Int J Cardiol. 2016 Oct 15;221:656-64. doi: 10.1016/j.ijcard.2016.06.153. Epub 2016 Jun 25.

PMID:
27423087
47.

The MANTA Vascular Closure Device: A Novel Device for Large-Bore Vessel Closure.

van Gils L, De Jaegere PP, Roubin G, Van Mieghem NM.

JACC Cardiovasc Interv. 2016 Jun 13;9(11):1195-6. doi: 10.1016/j.jcin.2016.03.010. No abstract available.

48.

Are BVS suitable for ACS patients? Support from a large single center real live registry.

Felix CM, Onuma Y, Fam JM, Diletti R, Ishibashi Y, Karanasos A, Everaert BRC, van Mieghem NMDA, Daemen J, de Jaegere PPT, Zijlstra F, Regar ES, van Geuns RJM.

Int J Cardiol. 2016 Sep 1;218:89-97. doi: 10.1016/j.ijcard.2016.05.037. Epub 2016 May 13.

49.

Reply.

van der Boon RM, van Domburg RT, de Jaegere PP.

Ann Thorac Surg. 2016 Jun;101(6):2425. doi: 10.1016/j.athoracsur.2016.02.032. No abstract available.

PMID:
27211966
50.

Determinants of image quality of rotational angiography for on-line assessment of frame geometry after transcatheter aortic valve implantation.

Rodríguez-Olivares R, El Faquir N, Rahhab Z, Maugenest AM, Van Mieghem NM, Schultz C, Lauritsch G, de Jaegere PP.

Int J Cardiovasc Imaging. 2016 Jul;32(7):1021-9. doi: 10.1007/s10554-016-0889-x. Epub 2016 May 2.

Supplemental Content

Loading ...
Support Center